comprehensive -WSS

comprehensive

author：fashion 2025-09-04 22:03:30 - browse：811

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

Intercept Pharmaceuticals, a firm whose treatment for a prevalent liver disease once made it the hottest stock in biotech, said Tuesday it would sell the company for less than $1 billion.

Alfasigma, an Italian pharmaceutical firm, will pay $19 a share for Intercept, in a roughly $800 million cash deal that represents an 80% premium to the company’s recent trading price. Intercept expects the deal to close by the end of the year.

The transaction comes three months after the Food and Drug Administration rejected Intercept’s treatment for NASH, an increasingly common fatty liver disease perceived as a potential gold mine by drug companies. Intercept’s medicine, called obeticholic acid, would have been the first approved treatment for NASH, but serious concerns about the risk of drug-related liver damage and uncertainty over whether its modest effects would improve patients’ lives made it unapprovable in the eyes of the FDA.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

focus

WSS

Parkinson’s finding may lead to tests and, someday, treatments

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Why scientists need input from humanists on sensitive research

Readout Newsletter: CAR

Test for long Covid? Researchers find new clue in blood samples

FDA advisers back CAR

focus

comprehensive

explore

Tori Bowie and the unacceptable rates of Black maternal death

First U.S. drug developed to treat liver disease MASH is approved

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

How to save health care price transparency rules

Peter Hotez and the public health issue of online harassment

RaDonda Vaught links Vanderbilt hospital issues to patient death

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

NIH director takes cautious approach to Biden drug pricing priority

Sports medicine is finally prioritizing gender equality

RaDonda Vaught links Vanderbilt hospital issues to patient death

knowledge

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Eli Lilly, Pfizer, and others want in on the online prescription market

UCLA team creates talking throat patch for voice disorders

EPA limits use of carcinogenic gas for sterilizing medical devices

NIH director takes cautious approach to Biden drug pricing priority

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

entertainment

focus

leisure time

Wikipedia